Overcoming the challenges of developing vaccines in an accelerated timeframe
accelerated development, assays, covid19, immunogenicity, R&D, SARS-CoV-2, vaccines
0 Comment
covid19
Rethinking trial engagement and recruitment starts with patient perspectives: patient survey insights
covid19, data analytics, demographics, diversity, IQVIA, patient perspectives, patient surveys, trial insights
0 Comment
Preventing the next pandemic: Learning the lessons
covid, covid19, pandemic, pharma, preventing the next pandemic, WHO
0 Comment
Delivering valuable independent medical education programmes
covid19, Digital transformation, EPG Health, medical education
0 Comment
Reviv Global and V-Health hope digital passport will reopen Vegas
covid19, digital health, digital passports, hospitality
0 Comment
How Big Data will accelerate the future of digital medicine in 2021
2021, covid19, digital medicine, pandemic, patient monitoring, telehealth, virtual care
0 Comment
The critical role of the generics sector during the pandemic
covid19, generic medicines, generics, supply chains
0 Comment
What HCPs think about COVID-19’s impact on cancer
cancer, covid19, diagnostics, HCPs, Oncology, What HCPs Think
0 Comment
A history of Pfizer
A history of..., BioNTech, covid19, Erhart, Pfizer, vaccine, Viagra
0 Comment
In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart…
1 2